Cargando…

Improving the Outcome of Leukemia by Natural Killer Cell-Based Immunotherapeutic Strategies

Blurring the boundary between innate and adaptive immune system, natural killer (NK) cells are widely recognized as potent anti-leukemia mediators. Alloreactive donor NK cells have been shown to improve the outcome of allogeneic stem-cell transplantation for leukemia. In addition, in vivo transfer o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chouaib, Salem, Pittari, Gianfranco, Nanbakhsh, Arash, El Ayoubi, Hanadi, Amsellem, Sophie, Bourhis, Jean-Henri, Spanholtz, Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956082/ https://www.ncbi.nlm.nih.gov/pubmed/24672522 http://dx.doi.org/10.3389/fimmu.2014.00095

Ejemplares similares

Underground Adaptation to a Hostile Environment: Acute Myeloid Leukemia vs. Natural Killer Cells
por: Dulphy, Nicolas, et al.
Publicado: (2016)

Revving up Natural Killer Cells and Cytokine-Induced Killer Cells Against Hematological Malignancies
por: Pittari, Gianfranco, et al.
Publicado: (2015)

Restoring Natural Killer Cell Immunity against Multiple Myeloma in the Era of New Drugs
por: Pittari, Gianfranco, et al.
Publicado: (2017)

Genetic Engineering of Natural Killer Cells for Enhanced Antitumor Function
por: Mantesso, Simone, et al.
Publicado: (2020)

Editorial: The immune escape mechanism and novel immunotherapeutic strategies of leukemia
por: Yu, Kang, et al.
Publicado: (2023)

Natural Killer Cells and Neuroblastoma: Tumor Recognition, Escape Mechanisms, and Possible Novel Immunotherapeutic Approaches
por: Bottino, Cristina, et al.
Publicado: (2014)

The Right Partner in Crime: Unlocking the Potential of the Anti-EGFR Antibody Cetuximab via Combination With Natural Killer Cell Chartering Immunotherapeutic Strategies
por: Baysal, Hasan, et al.
Publicado: (2021)

Natural Killer Cells for Cancer Immunotherapy: Pluripotent Stem Cells-Derived NK Cells as an Immunotherapeutic Perspective
por: Eguizabal, Cristina, et al.
Publicado: (2014)

The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments
por: Veluchamy, John P., et al.
Publicado: (2017)

Sugar Free: Novel Immunotherapeutic Approaches Targeting Siglecs and Sialic Acids to Enhance Natural Killer Cell Cytotoxicity Against Cancer
por: Daly, John, et al.
Publicado: (2019)

Editorial: Immunotherapeutic and Immunoprophylactic Strategies for Infectious Diseases
por: Sautto, Giuseppe A., et al.
Publicado: (2020)

Strategies to induce natural killer cell tolerance in xenotransplantation
por: Lopez, Kevin J., et al.
Publicado: (2022)

Synthetic glycolipid activators of natural killer T cells as immunotherapeutic agents
por: Carreño, Leandro J, et al.
Publicado: (2016)

Advancing Immunotherapeutic Vaccine Strategies Against Pulmonary Tuberculosis
por: Afkhami, Sam, et al.
Publicado: (2020)

Combined analysis of bulk and single-cell RNA sequencing reveals novel natural killer cell-related prognostic biomarkers for predicting immunotherapeutic response in hepatocellular carcinoma
por: Zhang, Kai, et al.
Publicado: (2023)

Natural Killer Defective Maturation Is Associated with Adverse Clinical Outcome in Patients with Acute Myeloid Leukemia
por: Chretien, Anne-Sophie, et al.
Publicado: (2017)

Manufacturing Natural Killer Cells as Medicinal Products
por: Chabannon, Christian, et al.
Publicado: (2016)

Editorial: Tailoring NK Cell Receptor–Ligand Interactions: An Art in Evolution
por: Koehl, Ulrike, et al.
Publicado: (2018)

Natural Killer Cells: From Basic Research to Treatments
por: Vivier, Eric, et al.
Publicado: (2011)

The More, The Better: “Do the Right Thing” For Natural Killer Immunotherapy in Acute Myeloid Leukemia
por: Parisi, Sarah, et al.
Publicado: (2017)

Natural Killer Cells Offer Differential Protection From Leukemia in Chinese Southern Han
por: Deng, Zhihui, et al.
Publicado: (2019)

Cathepsin G Is Expressed by Acute Lymphoblastic Leukemia and Is a Potential Immunotherapeutic Target
por: Khan, Maliha, et al.
Publicado: (2018)

Chronic IL-15 Stimulation and Impaired mTOR Signaling and Metabolism in Natural Killer Cells During Acute Myeloid Leukemia
por: Bou-Tayeh, Berna, et al.
Publicado: (2021)

Illuminating the dynamics of signal integration in Natural Killer cells
por: Pageon, Sophie V., et al.
Publicado: (2012)

Culture-Expanded Human Invariant Natural Killer T Cells Suppress T-Cell Alloreactivity and Eradicate Leukemia
por: Schmid, Hannes, et al.
Publicado: (2018)

Natural Killer Cell Subpopulations and Inhibitory Receptor Dynamics in Myelodysplastic Syndromes and Acute Myeloid Leukemia
por: Cianga, Vlad Andrei, et al.
Publicado: (2021)

Plasticity of natural killer cells in pregnant patients infected with SARS-CoV-2 and their neonates during childbirth
por: Carbonnel, Marie, et al.
Publicado: (2022)

Tipping the scales: Immunotherapeutic strategies that disrupt immunosuppression and promote immune activation
por: Santiago-Sánchez, Ginette S., et al.
Publicado: (2022)

Natural Killer Cells in Asthma
por: Karimi, Khalil, et al.
Publicado: (2013)

Uterine Natural Killer Cells
por: Sojka, Dorothy K., et al.
Publicado: (2019)

Natural Killer Cells in the Lungs
por: Cong, Jingjing, et al.
Publicado: (2019)

Editorial: Complement and Immunotherapeutics
por: Okrój, Marcin, et al.
Publicado: (2021)

A transient receptor potential channel-related model based on machine learning for evaluating tumor microenvironment and immunotherapeutic strategies in acute myeloid leukemia
por: Hua, Jingsheng, et al.
Publicado: (2022)

Natural Killer Cell-Derived Extracellular Vesicles as a Promising Immunotherapeutic Strategy for Cancer: A Systematic Review
por: Chan, Alvin Man Lung, et al.
Publicado: (2023)

Natural Killer Cell Responses in Hepatocellular Carcinoma: Implications for Novel Immunotherapeutic Approaches
por: Mantovani, Stefania, et al.
Publicado: (2020)

High-Grade Endometrial Stromal Sarcoma: Molecular Alterations and Potential Immunotherapeutic Strategies
por: Kim, Youngah, et al.
Publicado: (2022)

Editorial: Unveiling the tumor microenvironment by machine learning to develop new immunotherapeutic strategies
por: Zheng, Ping, et al.
Publicado: (2023)

From Natural Killer Cell Receptor Discovery to Characterization of Natural Killer Cell Defects in Primary Immunodeficiencies
por: Tabellini, Giovanna, et al.
Publicado: (2019)

Relative expression of receptors in uterine natural killer cells compared to peripheral blood natural killer cells
por: Ismail, Nurul Izza
Publicado: (2023)

Natural Killer Cells and Liver Fibrosis
por: Fasbender, Frank, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_pse6ggapa1mnallr57v3enggom